-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

627A.O2.6 627. Aggressive Lymphomas: Clinical and Epidemiological: Outcomes of Relapsed/Refractory DLBCL Treated with Immunochemotherapy, CAR-T Cell and Novel Agents

Symposia: Aggressive Lymphomas: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, epidemiology, Lymphomas, non-Hodgkin lymphoma, Clinical Research, B Cell lymphoma, Diseases, real-world evidence, aggressive lymphoma, Lymphoid Malignancies
Saturday, December 9, 2023: 4:00 PM-5:30 PM
Grand Hall C (Manchester Grand Hyatt San Diego)
Moderators:
Mehdi Hamadani, MD, The Medical College of Wisconsin Inc and Jeremy S. Abramson, MD, Massachusetts General Hospital Cancer Center
Disclosures:
Hamadani: ADC therapeutics: Consultancy, Honoraria, Research Funding, Speakers Bureau; Abbvie: Consultancy; Omeros: Consultancy; CRISPR: Consultancy; Genmab: Consultancy; Bristol Myers Squibb: Consultancy; Caribou: Consultancy; AstraZeneca: Speakers Bureau; Kite, a Gilead Company: Consultancy, Speakers Bureau; BeiGene: Speakers Bureau; Gamida Cell: Consultancy; Incyte: Consultancy; Genmab: Consultancy; Kadmon: Consultancy; Legend Biotech: Consultancy; MorphoSys: Consultancy; Novartis: Consultancy; SeaGen: Consultancy; Astra Zeneca: Speakers Bureau; BeiGene: Speakers Bureau; Sanofi Genzyme: Speakers Bureau; Astellas: Research Funding; Spectrum Pharmaceuticals: Research Funding; Takeda: Research Funding; Genentech: Honoraria; Myeloid Therapeutics: Honoraria. Abramson: AbbVie: Consultancy; AstraZeneca: Consultancy, Honoraria; BeiGene: Consultancy; BMS: Consultancy, Honoraria, Research Funding; Caribou Biosciences: Consultancy; Cellectar Biosciences: Consultancy; Century Therapeutics: Consultancy; Epizyme: Consultancy; Genentech: Consultancy; Genmab: Consultancy; Incyte: Consultancy; Interius: Consultancy; Janssen: Consultancy, Honoraria; Kite Pharma: Consultancy; Kymera: Consultancy; Lilly: Consultancy; Merck: Research Funding; MorphoSys: Consultancy; Mustang Bio: Consultancy, Research Funding; Ono Pharma: Consultancy; Regeneron: Consultancy, Honoraria; Seagen Inc.: Research Funding; Takeda: Consultancy; Celgene: Consultancy; Novartis: Consultancy; EMD Serono: Consultancy; Alimera Sciences: Consultancy; Karyopharm Therapeutics: Consultancy; C4 Therapeutics: Consultancy; Bluebird Bio: Consultancy; AI Therapeutics: Research Funding.
This session provides retrospective data on outcomes of patients with relapsed/refractory large B-cell lymphoma treated in the modern era with immunochemotherapy, CAR T-cell, and novel agents.
4:00 PM

Jean L. Koff, MD, MSc1, Melissa C. Larson, MS2*, Peter Martin, MD3, Jonathon B. Cohen, MD, MS4, Sabarish R. Ayyappan, MD5, Brian K. Link, MD6*, Thomas M. Habermann, MD7, Yucai Wang, MD, PhD7, Arushi Khurana, MBBS8, Grzegorz S. Nowakowski, MD7, Dai Chihara, MD, PhD9, Sara Haddadi10*, Izidore S. Lossos, MD11, Carla Casulo, MD12, Brad S. Kahl, MD13, Amy Ayers, MPH14*, Tanner W Reicks15*, Christopher R. Flowers, MD, MS9, James R. Cerhan, MD, PhD15, Matthew J. Maurer, DrMed15* and Loretta J. Nastoupil, MD14

1Winship Cancer Institute, Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA
2Department of Quantitative Health Sciences, Mayo Clinic College of Medicine, Rochester, MN
3Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY
4Winship Cancer Institute, Emory University, Atlanta, GA
5City of Hope Atlanta, Atlanta
6Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA
7Division of Hematology, Mayo Clinic, Rochester, MN
8Mayo Clinic, Rochester, MN
9Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
10Sylvester Comprehensive Cancer Center, Miami, FL
11Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
12Wilmot Cancer Center, University of Rochester, Rochester, NY
13Washington University School of Medicine in St. Louis, Saint Louis, MO
14MD Anderson Cancer Center, Houston, TX
15Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN

4:15 PM

Sanjal H. Desai, MBBS1,2, Nuttavut Sumransub, MD3, Rich Evans, PhD4*, Marcus P Watkins, PhD5*, Reem Karmali, MD, MSc6, Gaurav Goyal, MD7, Mitchell E. Hughes, PharmD8*, Arushi Khurana, MBBS2, Francisco J. Hernandez-Ilizaliturri, MD9, Joanna Zurko, MD10, Ayesha Hassan, MD11, Haris Hatic, DO12, Imran A. Nizamuddin, MD6, Andrew M Evens, DO, MBA, MMSc13, Andrea Carolina Anampa-Guzmán, MD14*, Yi Lin, MD, PhD15, Iris Isufi16, Mehdi Hamadani, MD17, Saurabh A Rajguru, MD18*, Naveena Lall19*, Aung M. Tun, MD20, Brian T. Hill, MD21, Deborah M. Stephens, DO22, Paolo F. Caimi, MD23, Daniel A. Ermann, MD22, Brad S. Kahl, MD24, Daniel J. Landsburg, MD25 and Grzegorz S. Nowakowski, MD26

1University of Minnesota, Saint Paul, MN
2Mayo Clinic, Rochester, MN
3Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN
4University of Minnesota, Minneapolis, MN
5Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
6Northwestern University, Chicago, IL
7Division of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL
8Hematology/Oncology Pharmacist, University of Pennsylvania Health System, Philadelphia, PA
9Roswell Park Comprehensive Cancer Center, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY
10MCW Cancer Center, Medical College of Wisconsin, Madison, WI
11Department of Medicine, West Virginia University, Morgantown, WV
12Suburban Hematology-Oncology Associates-Lawrenceville, Lawrenceville, GA
13Division of Blood Disorders, Rutgers Cancer Institute New Jersey, New Brunswick, NJ
14Roswell Park Comprehensive Cancer Center, Buffalo, NY
15Mayo Clinic Cancer Center, Rochester, MN
16Yale University School of Medicine, New Haven, CT
17Division of Hematology and Oncology, The Medical College of Wisconsin Inc, Milwaukee, WI
18Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI
19Rutgers University, New Brunswick
20The University of Kansas, Fairway, KS
21Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
22Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
23Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
24Washington University School of Medicine in St. Louis, Saint Louis, MO
25Department of Medicine, University of Pennsylvania, Philadelphia, PA
26Division of Hematology, Mayo Clinic, Rochester, MN

4:30 PM

Loretta J. Nastoupil, MD1, Clark R. Andersen, MS1*, Amy Ayers, MPH1*, Yucai Wang, MD, PhD2, Thomas M. Habermann, MD2, Dai Chihara, MD, PhD1, Brad S. Kahl, MD3, Brian K. Link, MD4*, Jonathon B. Cohen, MD, MS5, Peter Martin, MD6, Izidore S. Lossos, MD7, Carla Casulo, MD8, Ruitao Lin, PhD1*, Ziyi Li, PhD1*, Melissa C. Larson, MS2*, Matthew J. Maurer, DSc2, Lynn Huynh, DrPH, MBA, MPH9*, Chi Gao, ScD9*, Ramya Ramasubramanian, PhD, MPH9*, Mei Sheng Duh, RPh, MPH, ScD9, Alex Mutebi, PhD10*, Tongsheng Wang, MSc10*, Monika Jun, MPH10*, Anthony Wang, MPH, PhD11*, Rajesh Kamalakar, MS11*, Anupama Kalsekar, PhD10*, James R. Cerhan, MD, PhD2 and Christopher R. Flowers, MD, MS1

1MD Anderson Cancer Center, Houston, TX
2Mayo Clinic, Rochester, MN
3Washington University School of Medicine in St. Louis, St. Louis, MO
4University of Iowa Carver College of Medicine, Iowa City, IA
5Emory University, Atlanta, GA
6Weill Cornell Medical College, New York, NY
7University of Miami Health System, Miami, FL
8University of Rochester Medical Center, Rochester, NY
9Analysis Group, Inc., Boston, MA
10Genmab, Princeton, NJ
11AbbVie, Inc., Chicago, IL

4:45 PM

Gloria Iacoboni, MD1*, Angel Serna, MD1*, Victor Navarro Garces2*, Ana Jimenez Ubieto3*, Evelyn Valencia, MD4*, Alberto Lopez Garcia, MD5, Itziar Carro, MD6*, Sergi Camarillas, MD1*, Josu Iraola1*, Lucia Medina, MD3*, Gala Vega, MD5*, Maria Pozas, MD3*, Anna Maria Sureda Balari, MD, PhD6, Raul Cordoba, MD PhD5, Miguel Canales4*, Francesc Bosch, MD, PhD1*, Pere Barba, MD1 and Pau Abrisqueta Costa1*

1Vall d'Hebron University Hospital, Barcelona, Spain
2Oncology Data Science (ODysSey) Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
3Hospital Universitario 12 de Octubre, Madrid, Spain
4Department of Hematology, Clínica Universidad de Navarra; Hematology and Oncology Program, Center for Applied Medical Research (CIMA); Instituto de Investigaciones Sanitarias de Navarra (IdiSNA), Pamplona, Spain
5University Hospital Fundación Jiménez Díaz, Hematology Department, Madrid, Spain
6Hospital Duran i Reynals (Institut Català d'Oncologia), Hospitalet de Llobregat, Barcelona, Spain

5:00 PM

Aung M. Tun, MD1, Romil Patel, MD2, Frederique St-Pierre, MD3, Evguenia Ouchveridze, MD4, Alex Niu, MD5*, Jennifer Obasi6*, Allison C. Rosenthal, DO7, Priyanka A Pophali, MD8, Timothy S. Fenske, MD6*, Reem Karmali, MD, MSc9, Sairah Ahmed, MD2 and Patrick B Johnston, MD, PhD5*

1Division of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas, Westwood, KS
2Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Medicine, Division of Hematology/Oncology and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Northwestern University Feinberg School of Medicine, Chicago, IL
4Division of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas, Kansas City, KS
5Division of Hematology, Mayo Clinic, Rochester, MN
6Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
7Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ
8Carbone Cancer Center, University of Wisconsin, Madison, WI
9Northwestern University, Chicago, IL

5:15 PM

Emily Ayers, MD1, Viktoriya Zelikson, MD1, Ashwath Gurumurthi, MBBS2*, Yazeed Sawalha, MD3, Kaitlin Annunzio, DO3, Aditi Saha, MBBS4, Ning Dong, MD5*, David Augustus Qualls, MD6, Behzad Amoozgar, MD, MPH7*, Brad S. Kahl, MD7, John H. Baird, MD8, Pavan Challa, MD9*, Scott F. Huntington, MD, MPH, MSc9, Jennifer Santos, MD10*, Steven M. Bair, MD10, Mayur S. Narkhede, MBBS11, Shuning Li, MD12*, Zachary AK Frosch, MD, MSHP13, Carrie I Ho, MD14, Stephen D Smith, MD14, Allison Winter, MD15, Daniel J. Landsburg, MD16, Fateeha Furqan, MBBS17, Mehdi Hamadani, MD18, Katelin Baird, BS19*, Jason T. Romancik, MD19, Hanan Alharthy, MBBS20, Jennie Law, MD20, Leyla Bojanini, MD21*, Ranjana H. Advani, MD21, Boyu Hu, MD22, Patrick Connor Johnson, MD23, Natalie S. Grover, MD24, Debamita Kundu, PhD25*, Mwanasha Hamuza Merrill, MD26, Jennifer L Crombie, MD27, Nazila Shafagati, MD28, Cole Sterling, MD28, Loretta J. Nastoupil, MD29 and Narendranath Epperla, MD, MS3

1University of Virginia, Charlottesville, VA
2Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
3The James Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH
4Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL
5Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
6Dana Farber Cancer Institute, Boston
7Siteman Cancer Center, Division of Oncology, Washington University School of Medicine in St. Louis, Saint Louis, MO
8Department of Hematology and HCT, City of Hope National Medical Center, Duarte, CA
9Division of Hematology, Yale University, New Haven, CT
10Division of Hematology, University of Colorado - Anschutz Medical Campus, Aurora, CO
11Department of Hematology Oncology, University of Alabama at Birmingham, Birmingham, AL
12Fox Chase Cancer Center, Philadelphia, PA
13Department of Hematology/Oncology; Cancer Prevention and Control Research Program, Fox Chase Cancer Center, Philadelphia, PA
14Fred Hutchinson Cancer Center, Seattle, WA
15Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
16Department of Medicine, University of Pennsylvania, Philadelphia, PA
17Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
18Division of Hematology and Oncology, The Medical College of Wisconsin Inc, Milwaukee, WI
19Department of Hematology and Medical Oncology, Winship Cancer Institute at Emory University, Atlanta, GA
20University of Maryland, Baltimore
21Division of Oncology, Stanford University Institute, Stanford, CA
22Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
23Cancer Center, Massachusetts General Hospital, Boston, MA
24Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
25Division of Biostatistics, University of Virginia, Charlottesville
26Dana Farber Cancer Institute, Boston, MA
27Dana-Farber Cancer Institute, Boston, MA
28Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD
29MD Anderson Cancer Center, Houston, TX

*signifies non-member of ASH